These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 16220339

  • 1. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats.
    Torregrossa MM, Folk JE, Rice KC, Watson SJ, Woods JH.
    Psychopharmacology (Berl); 2005 Nov; 183(1):31-40. PubMed ID: 16220339
    [Abstract] [Full Text] [Related]

  • 2. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.
    Torregrossa MM, Isgor C, Folk JE, Rice KC, Watson SJ, Woods JH.
    Neuropsychopharmacology; 2004 Apr; 29(4):649-59. PubMed ID: 14647482
    [Abstract] [Full Text] [Related]

  • 3. Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats.
    Torregrossa MM, Jutkiewicz EM, Mosberg HI, Balboni G, Watson SJ, Woods JH.
    Brain Res; 2006 Jan 19; 1069(1):172-81. PubMed ID: 16364263
    [Abstract] [Full Text] [Related]

  • 4. Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.
    Zhang H, Torregrossa MM, Jutkiewicz EM, Shi YG, Rice KC, Woods JH, Watson SJ, Ko MC.
    Eur J Neurosci; 2006 Feb 19; 23(4):984-94. PubMed ID: 16519663
    [Abstract] [Full Text] [Related]

  • 5. Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies.
    Zhang H, Shi YG, Woods JH, Watson SJ, Ko MC.
    Eur J Pharmacol; 2007 Sep 10; 570(1-3):89-96. PubMed ID: 17601558
    [Abstract] [Full Text] [Related]

  • 6. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats.
    Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH.
    Psychopharmacology (Berl); 2002 Oct 10; 164(1):42-8. PubMed ID: 12373418
    [Abstract] [Full Text] [Related]

  • 7. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model.
    Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP.
    Behav Brain Res; 2001 Apr 08; 120(1):87-95. PubMed ID: 11173088
    [Abstract] [Full Text] [Related]

  • 8. Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects.
    Jutkiewicz EM, Torregrossa MM, Sobczyk-Kojiro K, Mosberg HI, Folk JE, Rice KC, Watson SJ, Woods JH.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):151-9. PubMed ID: 16442521
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats.
    Jutkiewicz EM, Rice KC, Traynor JR, Woods JH.
    Psychopharmacology (Berl); 2005 Nov 15; 182(4):588-96. PubMed ID: 16163520
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats.
    Rogóz Z, Skuza G, Legutko B.
    J Physiol Pharmacol; 2005 Dec 15; 56(4):661-71. PubMed ID: 16391422
    [Abstract] [Full Text] [Related]

  • 14. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.
    Jutkiewicz EM, Kaminsky ST, Rice KC, Traynor JR, Woods JH.
    J Pharmacol Exp Ther; 2005 Oct 15; 315(1):414-22. PubMed ID: 16014751
    [Abstract] [Full Text] [Related]

  • 15. Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal Cortex.
    Yan L, Xu X, He Z, Wang S, Zhao L, Qiu J, Wang D, Gong Z, Qiu X, Huang H.
    Biomed Res Int; 2020 Oct 15; 2020():2794263. PubMed ID: 32185198
    [Abstract] [Full Text] [Related]

  • 16. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise.
    Russo-Neustadt AA, Alejandre H, Garcia C, Ivy AS, Chen MJ.
    Neuropsychopharmacology; 2004 Dec 15; 29(12):2189-99. PubMed ID: 15199375
    [Abstract] [Full Text] [Related]

  • 17. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone.
    Dwivedi Y, Rizavi HS, Pandey GN.
    Neuroscience; 2006 Dec 15; 139(3):1017-29. PubMed ID: 16500030
    [Abstract] [Full Text] [Related]

  • 18. Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats.
    Sezen SF, Kenigs VA, Kapusta DR.
    J Pharmacol Exp Ther; 1998 Oct 15; 287(1):238-45. PubMed ID: 9765343
    [Abstract] [Full Text] [Related]

  • 19. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.
    Nibuya M, Morinobu S, Duman RS.
    J Neurosci; 1995 Nov 15; 15(11):7539-47. PubMed ID: 7472505
    [Abstract] [Full Text] [Related]

  • 20. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.
    Neuropharmacology; 2008 Nov 15; 55(6):1006-14. PubMed ID: 18761360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.